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Abstract The loading of antigenic peptides onto major
histocompatibility complex class I (MHC I) molecules is
an essential step in the adaptive immune response against
virally or malignantly transformed cells. The ER-resident
peptide-loading complex (PLC) consists of the transporter
associated with antigen processing (TAP1 and TAP2),
assembled with the auxiliary factors tapasin and MHC I.
Here, we demonstrated that the N-terminal extension of
each TAP subunit represents an autonomous domain,
named TMD0, which is correctly targeted to and inserted
into the ER membrane. In the absence of coreTAP, each
TMD0 recruits tapasin in a 1:1 stoichiometry. Although the
TMD0s lack known ER retention/retrieval signals, they are
localized to the ER membrane even in tapasin-deﬁcient
cells. We conclude that the TMD0s of TAP form autono-
mous interaction hubs linking antigen translocation into the
ER with peptide loading onto MHC I, hence ensuring a
major function in the integrity of the antigen-processing
machinery.
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Abbreviations
Crt Calreticulin
ER Endoplasmic reticulum
ERGIC ER-Golgi intermediate compartment
MHC I Major histocompatibility complex class I
PLC Peptide-loading complex
TAP Transporter associated with antigen processing
TMD Transmembrane domain
Tsn Tapasin
wt Wild-type
Introduction
The adaptive immune system of jawed vertebrates is
responsible for detection and elimination of virus-infected
or malignantly transformed cells, thus playing an essential
role in survival. Information about the cellular proteome is
presented to cytotoxic T cells on the cell surface in the
form of complexes of MHC I molecules with antigenic
peptides derived from intracellular proteins [1–3]. A large
portion of the cellular proteome is degraded by the pro-
teasome. A fraction of these antigenic peptides is
transported into the lumen of the endoplasmic reticulum
(ER) by the transporter associated with antigen processing
(TAP), a heterodimeric ABC complex composed of TAP1
(ABCB2) and TAP2 (ABCB3). The loading of peptides
onto MHC I takes place within the peptide-loading com-
plex (PLC), a multisubunit machinery consisting of TAP1/2,
MHC I heavy chain/b2-microglobulin, the chaperone
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123calreticulin, the oxidoreductase ERp57, and tapasin (Tsn).
The latter is an essential adapter molecule within the PLC,
as it bridges the peptide donor (TAP) with the peptide
acceptor (MHC I) [4, 5]. For a large number of MHC I
alleles, tapasin is required for loading of high-afﬁnity
peptides onto MHC I, a process known as peptide editing
[6, 7]. After loading their peptide cargo, MHC I complexes
travel via the secretory pathway to the cell surface. Large
efforts have been made to understand the assembly, orga-
nization, and function of the PLC. For most ER-lumenal
parts, structural information is available [8–12]. However,
TAP cannot yet be crystallized, and only a homology
model of the coreTAP complex is available based on the
X-ray structures of bacterial ABC transporter Sav1866 and
the NBD1 of TAP1 [13–15].
Each coreTAP subunit consists of six transmembrane
helices plus the nucleotide-binding domain. CoreTAP
shares signiﬁcant homology with other ABC transporters
and is necessary and sufﬁcient for peptide binding and
transport [16]. In contrast, the unique N-terminal domain
with four putative transmembrane-spanning segments,
called TMD0, shares no homology to any other known
protein. Deletion of the ﬁrst transmembrane-spanning
segment of TAP destroys its ability to interact with tapasin
[17]. However, there is no structural information available
for the TMD0 of TAP1 and TAP2. Despite their critical
role in PLC assembly, the TMD0s constitute the least
understood part of this macromolecular machinery. TMD0
of TAP2 (hereafter named TMD0
TAP2) is about 30 amino
acids shorter than that of TAP1 (TMD0
TAP1). Although their
sequences markedly differ, both TMD0s seem to fulﬁll
similar functions in tapasin binding [16], in spite of data
indicating a functional asymmetry of greater signiﬁcance
of the rat TMD0
TAP2 in PLC function [18]. In this study, the
functionality and structural integrity of the TMD0s of both
TAP subunits were addressed with regard to their subcel-
lular localization, binding, and stoichiometry of tapasin.
Materials and methods
Cloning and constructs
TMD0
TAP1 and TMD0
TAP2 were cloned into pcDNA3.1(?)
(Invitrogen, Darmstadt, Germany) via XhoI/EcoRI and
KpnI/NotI, respectively. To generate TMD0
TAP1 (aa 1–164
of TAP1) with a C-terminal myc-tag and TMD0
TAP2 (aa
1–127 of TAP2) with a C-terminal HA-tag, the following
primer pairs were used: 50-GTCGACGAATTCATGGC
TAGCTCTAGGTG-30 and 50-GTCGACCTCGAGTCACA
GATCCTCTTCTGAGATGAGTTTTTGTTCGGATCCG
CCGGGCACCCAG-30 for TMD0
TAP1,5 0-GTCGACGG
TACCAGATCTACCATGCGGCTCCCTGACCTG-30 and
50-GTCGACGCGGCCGCTCAAGCGTAGTCTGGGACG
TCGTATGGGTAGGATCCCTTCTCCTGGGCTCC-30
for TMD0
TAP2. CoreTAP1 (amino acids 165–748, containing
an N-terminal methionine) was ampliﬁed with primer pairs
50-CGATTACTCGAGATGGGTCAGGGCGGCTC-30and
50-CGATTAGAATTCCCTTCTGGAGCATCTGC-30 and
cloned into pEGFP-N3 (BD Biosciences, Franklin Lakes,
NJ, USA) via XhoI and EcoRI sites. CoreTAP2-mCerulean
(amino acids 125-716 plus N-terminal methionine) con-
taining a C-terminal StrepII-tag was ampliﬁed with the
primer pair 50-CATGCTTAAGATGGCCCAGGAGAAGG
AGCAGGACC-30and 50-CCGCTCGAGTCACTTCTCGA
ATTGTGGGTGAGACCAAGC-30, then cloned into
pcDNA3.1(?) via AﬂII and XhoI. Tsn-TMD0 constructs
were ampliﬁed via PCR with the following primers: 50-AG
ATCTATGAAGTCCCTGTCTCTGCTCCTCG -30 as for-
ward primer for both constructs, 50-ATCGCGGCCGCT
CACAGATCCTCTTCTGAGATGAGTTTTTGTTCACC
TCCAGGCACCCAAAGACTACC-30 for Tsn-TMD0
TAP1
containing a C-terminal myc-tag and 50-GTCGACGCGGC
CGCTCAAGCGTAGTCTGGGACGTCGTATGGGTAG
GATCCTTTTTCTTGGGCACCTGGTGGAC-30 for Tsn-
TMD0
TAP2 with a C-terminal HA-tag. A 34 amino acid long
ﬂexible glycine-serine linker was inserted between the
C-terminus of tapasin and the N-terminus of the TMD0.
Both constructs were cloned into pcDNA3.1(?) via Bam-
HI/NotI. For the TAP1/TAP2 coexpression plasmid, TAP1
was cloned into the MCS2 of pVitro2-neo-mcs (Invivogen,
San Diego, CA, USA) via BglII and NheI, TAP2 was
cloned into MCS1 via BamHI and SalI.
Cell lines and transfection
HeLa cells were cultured in DMEM (PAA Laboratories,
Pasching, Austria) supplemented with 10 % fetal calf
serum (FCS; Biochrom, Berlin, Germany). M553, a human
tapasin-deﬁcient melanoma cell line [19, 20], was main-
tained in RPMI 1640 with 10 % FCS. Transfection of
M553 was performed using XtremeGene HP (Roche,
Grenzach-Wyhlen, Germany) according to the manufac-
turer’s instructions. HeLa cells were transfected with
18 mM branched polyethyleneimine (PEI) with a DNA-to-
PEI ratio of one to three. After 24–48 h, cells were har-
vested and used for the indicated experiments.
Antibodies
For immunoﬂuorescence experiments, the following anti-
bodies were used: mouse anti-myc 4A6 (Millipore,
Billerica, MA, USA), mouse anti-HA HA-7 (Abcam,
Cambridge, UK), mouse anti-TAP1 148.3 [21], and mouse
anti-StrepII (IBA BioTAGnology, Go ¨ttingen, Germany).
As organelle makers, rabbit anti-Calreticulin (polyclonal
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ERGIC-53 (Sigma-Aldrich), and anti-GM130 (Golgi;
EP892Y; Abcam) were used. Detection of the primary
antibodies was done with donkey anti-mouse-Alexa488
(Invitrogen), goat anti-rabbit-Cy3 (Dianova, Hamburg,
Germany), and, for simultaneous detection of GFP and
StrepII together with organelle marker, goat anti-mouse-
Alexa633 (Invitrogen). For immunoblotting, anti-myc 4A6,
anti-HA HA-7, anti-SRP54 (BD Bioscience), anti-MHC I hc
HC10 [22] and mAb 7F6, raised against amino acids
21GPAVIECWFVEDASGKG35ofhumantapasin,wereused.
Membrane preparation and carbonate extraction
Membranes were prepared from 5 9 10
6 transiently
transfected HeLa cells. The cell pellet was mixed with
50 mM ice-cold Tris buffer (pH 7.3) containing 250 mM
sucrose and protease inhibitor mix (Serva, Heidelberg,
Germany). Cells were pulped with a glass homogenizer.
Post-nuclear supernatants were collected by centrifugation
for 10 min at 700g and membranes were sedimented by
centrifugation at 100,000g for 30 min at 4 C. Membranes
were resuspended in 0.1 M Na2CO3 buffer pH 11.5 and
incubated on ice for 15 min, followed by centrifugation at
100,000g for 20 min at 4 C. The supernatant was col-
lected. The remaining pellet was resuspended in carbonate
buffer pH 11.5, adjusted to 1.6 M sucrose and overlaid
with 1.25 M and 0.25 M sucrose in the same buffer.
Centrifugation was performed for 90 min at 100,000g and
the ﬂoating membranes were collected. Proteins were
precipitated by chloroform–methanol and subsequently
analyzed by SDS-PAGE (15 %).
Immunoﬂuorescence and image processing
Transiently transfected HeLa cells grown on cover slips
were ﬁxed 30 min with 4 % formaldehyde in PBS at room
temperature, quenched with 50 mM glycine for 10 min, and
permeabilized with 0.1 % Triton X-100 for 20 min. After
blocking with 5 % bovine serum albumin for 30 min,
cells were stained with the primary antibodies followed by
secondary antibodies for 1 h at room temperature. Nuclei
were visualized by DAPI staining (Dianova). Preparations
were mounted in 10 % (w/v) Mowiol (Calbiochem/Merck,
Nottingham, UK). Samples were analyzed with a confocal
laser-scanning microscope (LSM 510; Zeiss, Germany)
equipped with a Plan-Apochromat 63x/1.4 Oil DIC
objective. Deconvolution of the images was performed
using non-blind 2D deconvolution of AutoQuantX2
(MediaCybernetics, Bethesda, MD, USA). Non-transfected
cells were removed from the picture prior to determination
of Pearson’s coefﬁcients, and a threshold was manually set
to remove background. For colocalization analysis, the
JACoP plug-in [23] for ImageJ was used to calculate
Pearson’s coefﬁcients out of 8–10 individual cells per
construct and organelle marker. For coreTAP1 and core-
TAP2 co-expression, Pearson’s coefﬁcients were
calculated for coreTAP1-GFP and the organelle marker.
Coimmunoprecipitation
For coimmunoprecipitation, sheep anti-mouse Dynabeads
(Invitrogen) were loaded with mouse anti-myc 4A6
(TMD0
TAP1 and Tsn-TMD0
TAP1) or mouse anti-HA HA-7
(TMD0
TAP2 and Tsn-TMD0
TAP2) for 2 h at 4 C. Control
precipitations were performed using a non-speciﬁc isotype-
matched mouse antibody. After coating, the beads were
washed three times with 1 ml IP buffer containing 20 mM
Tris/HCl, pH 7.4, 0.1 % BSA, 150 mM NaCl, and 5 mM
MgCl2. For each sample, 2.5 9 10
6 HeLa cells were plated
in a 14.5-cm dish the day before the transfection. Then,
24 h (Tsn-TMD0s) or 48 h (TMD0s) after transfection, the
cells were harvested and solubilized in 1 ml buffer con-
taining 20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM
MgCl2, 1 % digitonin, and 1 % protease inhibitor mix
(Serva) for 1 h at 4 C. Solubilized cells were centrifuged
for 30 min at 100,000g at 4 C. After pre-clearing, the
supernatant was incubated with pre-coated magnetic beads
for 1 h at 4 C. After washing, beads were isolated by a
magnet and bound protein was eluted with 30 ll SDS
sample buffer for 10 min at 65 C. Eluates were analyzed
by SDS-PAGE and subsequent immunoblotting.
Protease K digestion
Membranes were prepared as described above. After centri-
fugation at 100,000g, membranes were resuspended in ice-
cold PBS containing 5 mM CaCl2. Proteinase K (0.6 units,
Sigma Aldrich) were added in the absence or presence of
0.1 % Triton-X 100, and incubated on ice for 30 min.
DigestionwasstoppedbytheadditionofPMSF(5 mMﬁnal),
followed by incubation at 95 C for 10 min in SDS sample
buffer. Samples were separated by SDS-PAGE (10 %) and
subsequent immunoblotting with the indicated antibodies.
Results
Expression and membrane insertion of the isolated
TMD0s
The coreTAP subunits can be expressed without affecting
membrane targeting, insertion, folding, dimerization, and
transport activity [16]. However, it remains open whether
the unique and extra TMD0 represents an autonomous
domain with the ability to fold independently of coreTAP
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thus divided human TAP1 and TAP2 into TMD0 and
coreTAP to further study their functions (Fig. 1a). The
boundary for dissection of the domains lies within the
second cytoplasmic loop, resulting in TMD0
TAP1 (aa 1–164)
and TMD0
TAP2 (aa 1–127). For immunodetection, the
TMD0s of TAP1 and TAP2 were tagged with a C-terminal
myc- and HA-epitope, respectively (Fig. 1b). Strikingly,
both TMD0s were expressed at high levels in transiently
transfected HeLa cells. TMD0
TAP1 as well as TMD0
TAP2
were found to be in the membrane fraction (20 and 16 kDa,
respectively) together with the integral type I membrane
protein tapasin and resistant to alkaline extraction, whereas
the peripheral membrane protein, the signal recognition
particle SRP54, is in the supernatant (Fig. 1b). These
results demonstrate that the TMD0 of each TAP subunit is
targeted and inserted as integral membrane proteins.
Subcellular localization of the TAP domains
The ER is the major compartment for MHC I peptide
loading, although TAP activity was also found in post-ER
compartments [24]. We therefore investigated the subcel-
lular localization of the N-terminal domains. HeLa cells
were transiently transfected with each TMD0 or wt TAP
and analyzed by immunoﬂuorescence microscopy (Fig. 2).
As expected, wt TAP was found to be mostly in the ER.
Both TMD0
TAP1 and TMD0
TAP2 co-localized to a large
extent with the ER. Minor fractions of both TMD0s were
found in the ERGIC. Interestingly, the overlap with the
ERGIC was more pronounced for TMD0
TAP2 than for
TMD0
TAP1. The colocalization with the Golgi marker
GM130 was only weak, demonstrating that isolated TMD0s
are efﬁciently retained in the early secretory pathway.
We next investigated the localization of coreTAP. Pre-
vious studies demonstrated the peptide transport activity of
the coreTAP complex into ER-derived microsomes from
Sf9 cells using a glycosylation dependent assay [16]. Due
to differences in the post-translational modiﬁcations
between the insect cell and mammalian cell system, this
evidence for ER retention of the coreTAP complex might
not necessarily be transferrable to human cells. To clarify
this point, coreTAP1 and coreTAP2 were fused C-termi-
nally to eGFP and mCerulean, respectively. Confocal laser
scanning microscopy directly visualized coreTAP1-eGFP,
whereas coreTAP2 was indirectly detected via its C-ter-
minal Strep-tag, due to its low expression level and the
relatively weak ﬂuorescence of the mCerulean. Similar to
the TMD0s, coreTAP1 and coreTAP2 localized to the ER
when expressed individually in HeLa cells (Fig. 3a, b).
Fig. 1 Unique N-terminal domains (TMD0s) of TAP1 and TAP2
represent an autonomous membrane protein fold. a Structural model
of the TAP complex [3, 11, 50]. CoreTAP is shown as a homology
model based on the structure of Sav1866 [13, 15]. The extra
N-terminal domain TMD0 of each TAP subunit, illustrated as a four-
helix bundle, recruits the tapasin-ERp57 conjugate via transmem-
brane domain interaction. b TMD0
TAP1 and TMD0
TAP2 are integral
membrane domains. Membranes were prepared from transiently
transfected HeLa cells and alkaline extraction was performed. I an
aliquot (1/10) of the membranes before alkaline extraction to conﬁrm
expression, M and S membrane fraction and supernatant after
treatment with carbonate buffer pH 11.5, respectively. Immunoblots
were developed against TMD0
TAP1/2, tapasin as integral type I
membrane protein, and SRP54 as peripheral membrane protein
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the formation of heterodimers with endogenous TAP. To
examine if heterodimers of both coreTAP subunits were
also restricted to the ER, we coexpressed coreTAP1 and
coreTAP2 (Fig. 3c). The Pearson’s coefﬁcients for the
tested compartments were similar to those of overexpres-
sed wt TAP (Fig. 2c), indicating that the coreTAP shows
the same subcellular distribution as wt TAP.
TMD0s of TAP1 and TAP2 form autonomous platforms
for tapasin recruitment
It has been previously demonstrated that the coreTAP
complex does not interact with tapasin [16, 17, 25]. Thus,
the tapasin-binding site could be formed at the interface of
TMD0 and coreTAP, or by the TMD0 alone. To distinguish
between these possibilities, coimmunoprecipitation exper-
iments were performed with the TMD0s of both TAP
subunits and endogenous tapasin in HeLa cells. TMD0
TAP1
and TMD0
TAP2 were precipitated using anti-myc or anti-HA
antibody, respectively (Fig. 4). Importantly, each TMD0
interacts with tapasin, conﬁrming that the TMD0s are
correctly folded and form an independent interaction
domain for tapasin.
TMD0s of TAP1 and TAP2 localize to the ER
independently of tapasin
TMD0
TAP1 and TMD0
TAP2 lack any known ER retention
signal but interact with tapasin, which harbors a di-lysine
ER retrieval signal [26]. We therefore asked whether
binding to tapasin retains the TMD0 in the ER. To address
this, we expressed wt TAP or the TMD0s in the tapasin-
deﬁcient cell line M553 [19, 20] and analyzed their sub-
cellular distribution by immunostaining (Fig. 5). Similar to
HeLa cells, wt TAP co-localized with the ER marker and
only a minimal fraction was found in the ERGIC and
Golgi. The same distribution was observed for TMD0
TAP1
and TMD0
TAP2, demonstrating that tapasin interaction is
expendable for correct localization. Again, the fraction of
TMD0
TAP2 that was found in the ERGIC was enhanced
compared to that of TMD0
TAP1.
Fig. 2 Subcellular localization of TMD0
TAP1/2. Indirect immunoﬂuo-
rescenceontransientlytransfectedHeLacells(TMD0sorwtTAP1/2as
acontrol)wasperformedusingTMD0
TAP1,TMD0
TAP2andTAP1speciﬁc
(myc, HA and 148.3, respectively, green) as well as organelle speciﬁc
antibodies [ER anti-calreticulin; ER-Golgi intermediate compartment
(ERGIC): ERGIC-53; Golgi GM-130; red]. a TMD0
TAP1, b TMD0
TAP2,
c wt TAP. Images were taken using confocal laser scanning micros-
copy. Pearson coefﬁcients were calculated from 8–10 individual
images. Scale bar 10 lm
b
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123Fig. 3 Subcellular localization
of coreTAP. HeLa cells were
transiently transfected with
coreTAP1-eGFP (a), coreTAP2-
mCerulean (b), or a
combination of both coreTAP
constructs (c), and analyzed by
confocal laser scanning
microscopy. CoreTAP2-
mCerulean was indirectly
visualized via its C-terminal
StrepII-tag with a StrepII
antibody. Organelles were
stained with antibodies against
marker proteins [ER anti-
calreticulin; ER-Golgi
intermediate compartment
(ERGIC): anti-ERGIC-53;
Golgi: anti-GM130]. Pearson
coefﬁcients were calculated
from 8 to 10 individual images.
Scale bar 10 lm
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How many tapasin molecules are present within a fully
assembled PLC is still a matter of debate. The tapasin-to-
TAP ratios reported varied from 1:1 and 2:1 to 4:1 [5, 27,
28]. To address this question, we tethered tapasin to the
TMD0 of each TAP subunit via a ﬂexible glycine–serine
linker of 34 aa, leading to Tsn-TMD0
TAP1 and Tsn-
TMD0
TAP2. As a result, the stoichiometry is ﬁxed and one
tapasin binding site is already occupied by the fused
tapasin (Fig. 6a). Similar to the isolated TMD0s, the fusion
constructs are located to the ER in HeLa cells, after tran-
sient expression (data not shown). Our recent experiments
targeting the topology of TAP2 revealed that the N-ter-
minus of TAP2 faces the cytosol. For further clariﬁcation,
the membrane topology of the fusion constructs was con-
ﬁrmed by Proteinase K treatment (Fig. 6b). The myc- or
HA-tag at C-terminus of Tsn-TMD0 was accessible from
the cytosol, where the ER-lumenal calreticulin is degraded
only after Triton-X 100 permeabilization of the membrane.
In addition, the linker is accessible for Proteinase K,
cleaving the tapasin from TMD0. These results demonstrate
the correct membrane insertion of tapasin and that the
linker and C-terminus of TMD0s are exposed to the cyto-
sol. By coimmunoprecipitation, we could demonstrate that
no additional, endogenous tapasin was recruited to Tsn-
TMD0
TAP1 or Tsn-TMD0
TAP2 (Fig. 6c), revealing that there
is only one single binding site for tapasin on each TMD0.
Although Tsn-TMD0
TAP1 recruited slightly less of MHC I
than Tsn-TMD0
TAP2, both Tsn-TMD0 fusion proteins were
Fig. 4 Recruitment of tapasin by TMD0
TAP1/2. TMD0
TAP1 or TMD0
TAP2
were transiently expressed in HeLa cells and subjected to coimmu-
noprecipitation using myc or HA antibodies. As mock control, an
isotype antibody was used. For both TMD0s, co-precipitation of
tapasin was observed. Asterisks: immunoglobulin heavy chain. The
solubilizate (S) represents 1/20 aliquot of the precipitate
Fig. 5 Subcellular localization of TMD0
TAP1 and TMD0
TAP2 in tapasin
deﬁcient cells. TMD0
TAP1 (a), TMD0
TAP2 (b), and wt TAP1/2 (c) were
transiently expressed in the tapasin deﬁcient cell line M553, stained
with the antibodies as indicated in Fig. 2, and analyzed via indirect
immunoﬂuorescence. Organelles were stained with antibodies against
marker proteins [ER anti-calreticulin; ER-Golgi intermediate com-
partment (ERGIC): anti-ERGIC-53; Golgi: anti-GM130]. Pearson
coefﬁcients were calculated from 8 to 10 individual images. Scale bar
10 lm
c
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folded and functional.
Discussion
In this study, we demonstrated that the isolated TMD0so f
TAP1 and TAP2 are independently targeted to the ER mem-
brane and form autonomous interaction hubs for tapasin
recruitment.TheyarenotrequiredfortheERlocalizationand
transport function of the coreTAP complex [16]. A similar
functional partition into a core ABC transport complex and
extra N-terminal domains was shown for other ABC trans-
porters. Some of these N-terminal extensions have an impact
on the subcellular trafﬁcking or function of the ABC trans-
porter, while others seem to serve different purposes,
extending the fascinating properties of ABC transporters
towards receptor and channel functions. The lysosomal
polypeptide transporter ABCB9 (TAP-like), which forms a
homodimeric complex, possesses a TMD0 that can be
expressed separately. Although this TMD0 is dispensable for
mere transport activity, it is required for the lysosomal
localization of the transporter. The core transport complex
lacking the TMD0s is targeted to the plasma membrane but
redirected into lysosomes upon separate expression of TMD0
[29]. However, an intrinsic afﬁnity of TMD0 for the core
translocation complex, as seen for ABCB9, was not observed
for TAP (data not shown).
Mitochondrial ABC transporters, also members of the
ABCB family, have N-terminal extensions containing very
long mitochondrial pre-sequences [30–32]. In contrast to
non-mitochondrial ABC transporters, these N-terminal
extensions are not membrane spanning per se. Neverthe-
less, they are essential for correct targeting, since deletion
of the leader sequence in ABCB10 and its yeast homologue
MDL1 resulted in mistargeting of the transporter to the ER
membrane [31, 32]. Vice versa, fusion of the N-terminal
extension of ABCB7 (residue 1–135) to the dihydrofolate
reductase leads to mitochondrial targeting of the fusion
protein [30].
Fig. 6 Each TMD0 harbors one
single tapasin-binding site.
a Model of the Tsn-TMD0
TAP1/2
fusion constructs interacting
with MHC I molecules.
b Membrane topology of the
Tsn-TMD0
TAP1/2 fusion
constructs. Crude membranes
were prepared from HeLa cells
transiently transfected with Tsn-
TMD0
TAP1 or Tsn-TMD0
TAP2.
Membranes (Membr.) were
treated with Proteinase K (0.6
units) in the absence or presence
of Triton-X 100 (T-X 100) for
30 min on ice followed by
immunoblotting. c Tsn-
TMD0
TAP1 or Tsn-TMD0
TAP2
were transiently expressed in
HeLa cells and subjected to
coimmunoprecipitation with
anti-myc, anti-HA, or an isotype
control antibody. Asterisks:
immunoglobulin heavy chain.
The solubilizate (S) represents
1/20 aliquot of the precipitate
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also display an extra N-terminal domain (named MSD or
TMD0), which typically comprises ﬁve transmembrane-
spanning segments (reviewed in [33]). MRP1 and MRP2,
for example, harbor TMD0s with strategic functions in
targeting of the transporters to the plasma membrane [34,
35]. As for TAP, the TMD0 of MRP1 is dispensable for
transport activity per se [36]. The sulfonylurea receptor
SUR1 (ABCC8) is the regulatory subunit of the KATP
channel KIR6.2. Mutations in KIR6.2 are associated with
congenital hyperinsulinism [37, 38] and neonatal diabetes
[39, 40]. TMD0
SUR1 is the interaction and regulation domain
to KIR6.2 [41, 42]. The TMD0
SUR1, expressed in the absence
of the remaining core ABC transporter, retains its ability to
associate with and gate KIR6.2 [43]. In conclusion, some
ABC transporters present an interesting division of work
using several independent membrane-spanning domains:
one forming the gated translocation pathway and one with
functions in regulation, trafﬁcking, or binding of interac-
tion partners. However, the TMD0s of TAP1 and TAP2
constitute prime examples of ER-resident ABC proteins.
A number of mechanisms are known that retain or
retrieve proteins in or to the ER. Soluble proteins are
retrieved from post-ER compartments by the KDEL motif
that binds to the KDEL receptor. For type I membrane
proteins, C-terminal di-lysine motifs (KKxx or KxKxx)
interact with COPI vesicles for retrieval to the ER [44].
Type II membrane proteins are retained by a double-argi-
nine motif at the N-terminus [45]. However, neither
coreTAP nor any of the TMD0s contain these characteristic
signals. Nevertheless, direct evidence for ER localization
of both TMD0s is delivered in this work by immunoﬂuo-
rescence analysis. TMD0
TAP1 and TMD0
TAP2 were
predominantly found in the ER, with a minor fraction
entering the post-ER compartment, ERGIC. This distribu-
tion resembles that of wt TAP and is in agreement with a
previous study that found a minor fraction of TAP active in
the ERGIC [24]. Of note, the escape of TMD0
TAP2 into the
ERGIC is enhanced compared to TMD0
TAP1. These data
imply that the TMD0s of both TAP subunits are retained in
the ER, but the unidentiﬁed retention or retrieval factor acts
more strongly in TMD0
TAP1 than in TMD0
TAP2. This reten-
tion/retrieval signal must be directly located within each
TMD0, because ER localization is not mediated by the
interaction with the KKxx motif-containing partner tapasin.
The localization of wt TAP was formerly suggested to be
independent of tapasin [24]. Here, we demonstrate that this
is also the case for the isolated membrane interaction hubs
TMD0 of TAP1 and TAP2. In addition, we provide direct
evidence that coreTAP1 and coreTAP2 localize to the ER
membrane. Escape to post-ER compartments was weak and
comparable to that of full-length TAP, demonstrating that
the mechanism for TAP ER retention is preserved in
coreTAP.
The observation that the independently expressed
TMD0s of both TAP subunits are able to recruit tapasin
gives direct evidence that the TMD0s are folded and
functional independent of coreTAP. Furthermore, coim-
munoprecipitation experiments with Tsn-TMD0 fusions
demonstrate that each TMD0 only bears one single binding
site for tapasin. This suggests a tapasin-to-TAP subunit
ratio of 1:1, which is in perfect agreement with the latest
study on this subject [28]. However, we cannot formally
rule out the possibility that a second tapasin-binding site is
formed by combination of the very C-terminal parts of
TMD0
TAP1 and TMD0
TAP2 as well as the N-terminus of
coreTAP1 and coreTAP2. Tsn-TMD0
TAP1 was reproducibly
found to recruit less MHC I than Tsn-TMD0
TAP2 (Fig. 6).
This might reﬂect a greater importance for TMD0
TAP2 in
MHC I loading. This is a reasonable speculation, since for
chicken and all other avian MHC I loci sequenced so far,
only TAP2 harbors a TMD0, while TAP1 has no TMD0 and
is therefore equivalent to coreTAP1 [46, 47]. The exact
interaction sites of TMD0
TAP1 and TMD0
TAP2 for tapasin
remain unknown. For tapasin, a number of candidate res-
idues have been proposed, including residues F397, F401,
G405, K408, and W412 of mouse tapasin [48], and K408
of human tapasin [49]. For TAP, it was previously shown
that removal of the ﬁrst transmembrane helix destroys the
tapasin-TAP interaction [17]. Whether this is due to an
altered overall folding of the truncated N-terminal domain
or missing essential residues will require future approa-
ches. The structural analysis of the TMD is one approach to
resolve this important interaction hub.
In conclusion, we show for the ﬁrst time that the TMD0s
of both TAP subunits form autonomous interaction scaf-
folds for the assembly of the MHC I peptide-loading
complex in the ER membrane. Each TMD0 connects
ERp57, calreticulin, and peptide-receptive MHC I via a
single tapasin molecule to the peptide supplier TAP.
According to this, the PLC can be subdivided into three
functional modules: (1) peptide binding and transport by
the coreTAP complex, (2) peptide loading and editing by
the Tsn-ERp57/MHC I subcomplex, and (3) the conjunc-
tion of these functions, accomplished by the interaction
hubs TMD0
TAP1 and TMD0
TAP2.
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